In an extremely preterm infant (<28 weeks) with facial‑femoral syndrome, bilateral femoral hypoplasia, cleft palate causing aspiration, patent ductus arteriosus and pneumonia, what is the step‑by‑step pathophysiology leading to bronchopulmonary dysplasia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pathophysiology of Bronchopulmonary Dysplasia in an Extremely Preterm Infant with Multiple Comorbidities

In this extremely preterm infant (<28 weeks), bronchopulmonary dysplasia develops through a cascade of lung injury mechanisms initiated by extreme prematurity itself, then amplified by mechanical ventilation, oxygen toxicity, aspiration from cleft palate, pneumonia-induced inflammation, and hemodynamic stress from the patent ductus arteriosus.

Step 1: Extreme Prematurity Arrests Lung Development

  • Birth at <28 weeks gestation occurs during the canalicular stage (16-26 weeks) or early saccular stage (26-36 weeks) of lung development, when alveolarization is incomplete and surfactant production is insufficient 1.
  • The immature lung has inadequate antioxidant defenses, making it especially vulnerable to oxygen-derived free radical injury 1.
  • Extreme prematurity (<30 weeks) is the single most important risk factor for BPD, with roughly one-third of such infants developing the condition 1.
  • This developmental arrest creates the substrate for "new BPD," characterized by alveolar simplification rather than the fibrosis seen in older forms of the disease 2, 1.

Step 2: Surfactant Deficiency Triggers Respiratory Distress Syndrome

  • Insufficient surfactant production leads to alveolar collapse, atelectasis, and severe respiratory distress requiring mechanical ventilation 2, 3.
  • The resulting hypoxemia necessitates supplemental oxygen therapy, initiating the second major pathway to lung injury 1.

Step 3: Mechanical Ventilation Causes Barotrauma/Volutrauma

  • Positive-pressure ventilation delivers repetitive stretch injury to the immature alveolar-capillary membrane 1.
  • Barotrauma is recognized as one of the two major contributors to BPD pathogenesis, alongside oxygen toxicity 1.
  • Ventilator-induced injury can cause pulmonary interstitial emphysema, which is strongly associated with subsequent BPD development 1.
  • The most severe long-term lung function abnormalities occur in children who required neonatal ventilation 1.

Step 4: Oxygen Toxicity Produces Biochemical and Structural Damage

  • Prolonged exposure to high oxygen concentrations generates reactive oxygen species that overwhelm the immature antioxidant system 1.
  • Peak lipid peroxidation occurs around postnatal day 5, damaging cell membranes and proteins 1.
  • Oxygen toxicity produces more pronounced physiological, inflammatory, and histologic changes than barotrauma alone 1.
  • The immature lung is typically exposed simultaneously to both oxygen toxicity and barotrauma, creating synergistic injury 1.

Step 5: Cleft Palate Causes Recurrent Aspiration

  • The posterior cleft palate in this infant with facial-femoral syndrome 4, 5 causes swallowing dysfunction and aspiration of oral secretions and feeds 2.
  • Aspiration leads to direct pulmonary inflammation, bronchospasm, and recurrent lower respiratory tract injury 2.
  • Gastroesophageal reflux (common in preterm infants) combined with aspiration is a frequent cause of failure to improve pulmonary status in infants with chronic lung disease 2.
  • Chronic aspiration perpetuates airway inflammation and prevents healing of injured lung tissue 2.

Step 6: Pneumonia Amplifies Inflammatory Cascade

  • Postnatal infections markedly increase BPD risk, with a relative risk of approximately 1.9 in infants weighing <1250 g 1.
  • Pneumonia triggers release of proinflammatory cytokines including IL-1, IL-6, IL-8, and TNF-α from alveolar macrophages 2.
  • IL-8 induces neutrophil chemotaxis, perpetuating inflammatory cell infiltration 2.
  • TNF-α and IL-1 induce fibroblast collagen production, contributing to pulmonary fibrosis 2.
  • The preterm infant's lung macrophages show deficient expression of antiinflammatory cytokine IL-10, predisposing to chronic lung inflammation 2.

Step 7: Patent Ductus Arteriosus Creates Hemodynamic Stress

  • The PDA creates a left-to-right shunt that increases pulmonary blood flow and causes pulmonary vascular congestion 6, 7.
  • PDA is consistently associated with BPD, particularly in extremely low-birth-weight infants 1.
  • After adjustment for confounders, PDA presence increases the odds of BPD-associated pulmonary hypertension by 4.29-fold 6.
  • Each additional month of PDA exposure increases the probability of BPD or death 6.
  • Nosocomial infection occurring temporally with PDA further potentiates the risk of chronic lung disease 1.
  • Increased pulmonary blood flow from the PDA causes lung water accumulation, decreased lung compliance, and increased airway resistance 2.

Step 8: Convergence into Chronic Lung Injury

  • The cumulative effect of multiple insults (extreme prematurity, mechanical ventilation, oxygen, aspiration, infection, and PDA) creates exponentially higher BPD risk than any single factor alone 1.
  • Inflammatory mediators including leukotrienes, platelet-activating factor, and complement components perpetuate ongoing tissue damage 2.
  • Central airway injury from prolonged intubation causes epithelial metaplasia, loss of ciliated epithelium, and mucous gland hypertrophy 2.
  • Vascular changes including smooth muscle hypertrophy and peripheral extension of muscularized vessels contribute to pulmonary hypertension 2.

Step 9: Arrested Alveolarization Defines "New BPD"

  • The combination of inflammatory injury and interrupted development results in uniformly arrested alveolar development rather than heterogeneous fibrosis 2.
  • Alveolar simplification with reduced surface area for gas exchange becomes the dominant pathologic feature 2, 1.
  • This pattern reflects injury occurring during the saccular phase of lung development in extremely preterm infants 2.

Step 10: Chronic Oxygen Dependence and Respiratory Morbidity

  • By definition, BPD is diagnosed when oxygen requirement persists beyond 28 days of postnatal life or beyond 36 weeks postmenstrual age, depending on gestational age at birth 2.
  • The damaged lung exhibits decreased compliance (30-50% of normal values), increased airway resistance, and abnormal gas exchange 2.
  • Chronic hypoxemia, if uncorrected, can lead to pulmonary hypertension, right ventricular hypertrophy, and cor pulmonale 2.

Critical Pitfalls in This Case

  • Aspiration is often underrecognized: In an infant with cleft palate and chronic lung disease, failure to control aspiration will prevent pulmonary improvement regardless of other interventions 2.
  • PDA management timing matters: The duration of PDA exposure, not just its presence, correlates with BPD-PH development, suggesting earlier closure may be beneficial in selected cases 6.
  • Infection prevention is paramount: Each episode of pneumonia or sepsis resets the inflammatory cascade and worsens long-term outcomes 1.
  • Nutritional failure perpetuates lung injury: Malnutrition delays lung growth, chest wall development, and alveolar healing, creating a vicious cycle 2.

References

Guideline

Risk Factors and Pathogenesis of Bronchopulmonary Dysplasia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Neonatal and Pediatric Lung Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Femoral Hypoplasia with Unusual Facies Syndrome.

Journal of clinical and diagnostic research : JCDR, 2017

Research

Prenatal diagnosis of femoral-facial syndrome: case report.

Journal of clinical ultrasound : JCU, 2014

Research

Patent Ductus Arteriosus and Development of Bronchopulmonary Dysplasia-associated Pulmonary Hypertension.

American journal of respiratory and critical care medicine, 2023

Related Questions

What type of orthopedic specialist is best for treating femoral hypoplasia unusual facies syndrome (FHUF)?
What treatment options are available for adults with femoral hypoplasia unusual facies syndrome?
What is the pathophysiology underlying pneumonia, high‑risk bronchopulmonary dysplasia, patent ductus arteriosus, facial‑femoral syndrome, incomplete cleft palate, and severe wasting in a premature infant with multiple congenital anomalies?
For an extremely preterm infant with bronchopulmonary dysplasia, patent ductus arteriosus, gastro‑oesophageal reflux, and pulmonary hypertension, which step of the supportive‑care cascade corresponds to each of the following medications: vitamin D3 400 IU drops, ferrous sulfate, multivitamin drops, folic‑acid drops, esomeprazole 2.5 mg, domperidone 1 mg/mL, furosemide 2 mg, sildenafil 1 mg, and lactulose 3.3 g/5 mL?
What is the most effective first‑line treatment for meibomian gland dysfunction to clear clogged meibomian gland orifices?
An adult with a serum 25‑hydroxy‑vitamin D level of 17.07 ng/mL who is taking 5,000 International Units of vitamin D daily—what is the appropriate dosing regimen to correct the deficiency?
How should I manage a metal puncture wound on my finger that has developed a blister?
Which neurological disorders increase sodium-sensitive hypertension?
Can omalizumab (Xolair) injections be used to treat IgE‑mediated food allergy?
What are the appropriate adult dosing regimens, contraindications, monitoring requirements, and alternative therapies for metoprolol?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.